Back to the Top 100
Iterative Health logo

Rank 26AI & Clinical Intelligence

Iterative Health

Develops AI-powered diagnostic software for precision gastroenterology, helping physicians interpret endoscopic images in real time.

Visit website
Signal Score
91.4
Total raised
$195M
Stage
Series B
Founded
2017
Headquarters
Boston, USA
Region
North America

Their signal

Pioneering computer vision in gastroenterology to standardize inflammatory bowel disease measurement and improve polyp detection rates during clinical screenings.

Signal Score 91.4editorial estimate, see how it is built
Capital (25% weight)93

Total raised, quality of investors and recency of the last round.

Growth (25% weight)90

Revenue trajectory, customer count, hiring and market pull.

Clinical & regulatory (20% weight)93

Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.

Team (15% weight)91

Founder track record, clinical depth on the bench and technical leadership.

Online visibility (15% weight)89

Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.

Also in AI & Clinical Intelligence

Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.